Modulation of galenic formulations of a topical sodium thiosulfate for the treatment of ectopic calcifications

20 March 2018

S. Molignier 1, E. Caudron2,3, K. Kemel3, C. Laugel3, J. Jost1,4, V. Guigonis5,6, V. Ratsimbazafy1,4 1 Service Pharmacie, CHU Dupuytren, Limoges, France
2 Service Pharmacie, Hôpital européen Georges Pompidou, AP-HP, Paris, France
3 Lip(Sys), Chimie analytique pharmaceutique, Université Paris Sud, Paris Saclay, Chatenay-Malabry, France.
4 UMR 1094, Université de Limoges, France
5 Service de Pédiatrie, CHU Dupuytren, Limoges, France
6 UMR 7276, Université de Limoges, France


Ectopic calcifications could be treated with sodium thiosulphate (TSS) by dermal application. In a patient, with a specific formula a calcification has been cure on the lower limb but not the part on the fluteal muscle. This lack of diffusion may be solved by improving passage through the stratum corneum of the skin. The objective of this work was to improve the depth diffusion of the TSS.


The first formula has been modified by changing excipients. New pharmaceutical formulation (including gels) containing permeation enhancers have been tested, before being galenicaly characterized.
The passage of TSS through the skin was determined by permeation test on Frantz cells, followed by assay by HPLC-UV in the receptor liquid, the dermis and the epidermis. This assessment has been completed by a microscopic study and the pH measurement.


Two ointments and five gels were evaluated. Concerning organoleptic features, visual aspect and spreading were satisfactory; pungent odor emitted by the TSS by degradation was not observed.
The permeation test of the ointments confirmed the low level of active ingredient in the receptor fluid. On the other hand, the gels have an interesting penetration profile with a passage beyond the various skin layers. The microscopic assessment shown an homogeneity and the measured pH was appropriate for a cutaneous administration.

Discussion - Conclusion

Results with gels were encouraging, making modulation of our formulation possible in order to increase the TSS skin penetration. After selection of the most appropriate formulation, a stability study will be carried out.

Discussion forum

GERPAC provides for its members a discussion forum specifically devoted to technology in hospital pharmacy

Access forum

Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data
Réalisation : Développeur web WordPress & SPIP freelance